Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University...
-
Upload
amice-douglas -
Category
Documents
-
view
218 -
download
0
Transcript of Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University...
![Page 1: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/1.jpg)
Sleep-Disordered Breathing and Stroke
Klar Yaggi, M.D., M.P.H.Assistant Professor
Yale University School of MedicineClinical Epidemiology Research Center (CERC)
Medical Director, VA CT Center for Sleep Medicine
![Page 2: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/2.jpg)
Journal of the Canadian Medical Association; 2006
![Page 3: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/3.jpg)
![Page 4: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/4.jpg)
![Page 5: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/5.jpg)
No relevant conflicts of interest
![Page 6: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/6.jpg)
Outline
• Epidemiologic evidence linking sleep-disordered breathing to cerebrovascular outcomes
• Mechanisms of stroke in sleep-disordered breathing
• Impact of CPAP treatment on cerebrovascular risk
![Page 7: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/7.jpg)
Outline
• Epidemiologic evidence linking sleep-disordered breathing to cerebrovascular outcomes
![Page 8: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/8.jpg)
Sleep Apnea Cycle
VentilatioVentilationn
ApneaApnea
ArousalArousal
SleeSleepp
Hypoxia
Pleural pressure Δ
Sympathetic activation
Reoxygenation
![Page 9: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/9.jpg)
Sleep Apnea and Diurnal Hypertension
Peppard; NEJM 2000
Apnea Hyponea Index0
> 0 - < 5≥ 5- <15
≥15
Adjusted* Odds Ratio Reference
1.422.032.89
*adjusted for baseline hypertension, age, gender, BMI, waist circumference, alcohol, and tobacco use
P for trend=0.002
![Page 10: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/10.jpg)
Sleep Apnea among Patients with Stroke
Yaggi; Lancet Neurology 2003
Source
Study Design (N)
Confounding
adjustment
Prevalence of Sleep Apnea
Mohsenin
1995
Cross-sectional
(20)
Age, BMI, HTN, smoking
80%
Dyken
1997
Case-control
(43)
Age, sex 71%
Basetti
1999
Case-control
(153)
Age, BMI, diabetes, stroke severity
63%
Parra
2001
Cross-sectional
(161)
Age, race, sex, smoking, diabetes, HTN, BMI, Lipids
61%
![Page 11: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/11.jpg)
Cerebrovascular Outcomes
Stroke leading to Sleep Apnea?
Askenasy; Stroke 1988
![Page 12: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/12.jpg)
Sleep Apnea leading to Stroke?
• OSA strongly associated with Transient Ischemic Attacks (TIA)
• Persistent OSA post-stroke with resolution of neuromuscular weakness
• No consistent type/location of stroke in association with sleep apnea
• Stroke does not cause most sleep apnea
Neau; Sleep Med Rev 2002
![Page 13: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/13.jpg)
Cerebrovascular Outcomes
Causal Direction?
![Page 14: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/14.jpg)
Cerebrovascular Outcomes
Confounding?
Central Obesity-Hypertension-Diabetes-Lipids
![Page 15: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/15.jpg)
Yale Study Design
Eligible Participants(without stroke)N=1022
(-)OSAN=325 (32%)
(+)OSAN=697(68%)
(+)TIA, Stroke,Death
(-) TIA, Stroke,Death
(+)TIA, Stroke,Death
(-) TIA, Stroke,Death
3-6 years of follow-up
![Page 16: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/16.jpg)
Kaplan-Meier Estimates of the Probability of Event-free Survival among Patients with the Obstructive Sleep Apnea Syndrome and Controls
Yaggi, H. et al. N Engl J Med 2005;353:2034-2041
Event-free Survival (TIA, Stroke, Death)
Yaggi; NEJM 2005
![Page 17: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/17.jpg)
Dose-Response (Trend) Analysis
Yaggi; NEJM 2005
P=0.005 (Chi-square test for linear trend)
Severity of Syndrome
Stroke or Death
No. of events No. of patients
Follow-up
yrs.
Hazard Ratio
(95% C.I.)
AHI ≤ 3 (ref) 13 271 3.08 1.00
AHI 4-12 21 258 3.06 1.75
(0.88-3.49)
AHI 13-36 20 243 3.09 1.74
(0.87-3.51)
AHI >36 34 250 2.78 3.30
(1.74-6.26)
![Page 18: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/18.jpg)
Risk of Stroke or Death
Yaggi; NEJM 2005
Covariate
Unadjusted Hazard Ratio
(95% C.I.)
Adjusted Hazard Ratio
(95% C.I.)
Age (yrs) 1.09 (1.06-1.11) 1.08 (1.06-1.11)
Male sex 0.99 (0.62-1.60) 0.78 (0.48-1.28)
Body Mass Index 0.99 (0.97-1.02) 0.99 (0.96-1.02)
Current Smoker 1.21 (0.90-1.64) 1.46 (0.78-2.98)
Diabetes Mellitus 1.56 (1.02-2.59) 1.31 (0.76-1.26)
Hyperlipidemia 1.04 (0.64-1.68) 1.01 (0.61-1.66)
Hypertension 1.48 (0.95-2.28) 1.20 (0.75-1.90)
Atrial Fibrillation 1.56 (0.79-3.12) 0.91 (0.45-1.86)
Obstructive Sleep Apnea 2.24 (1.30-3.86) 1.97 (1.12-3.28)
![Page 19: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/19.jpg)
Risk of Coronary Artery Events or CV Death
Yaggi/Shah; Sleep and Breathing 2009
Covariate
Unadjusted Hazard Ratio
(95% CI)
Adjusted Hazard Ratio
(95% CI)
Age ( per yr) 1.07 (1.04-1.09) 1.08 (1.05-1.10)
Tobacco use 1.96 (1.12-3.42) 2.52 (1.43-4.44)
Male gender 1.45 (0.87-2.41) 1.30 (0.77-2.21)
Body Mass Index 1.02 (0.99-1.04) 1.02 (0.99-1.05)
Current Smoker 1.33 (0.86-2.07) 1.92 (1.22-3.02)
Diabetes 1.94 (1.18-3.17) 1.42 (0.85-2.39)
Hyperlipidemia 1.62 (1.05-2.52) 1.46 (0.93-2.30)
Hypertension 1.83 (1.16-2.88) 1.40 (0.87-2.25)
Obstructive Sleep Apnea 2.57 (1.39-4.72) 2.05 (1.10-3.84)
![Page 20: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/20.jpg)
Patient Prognostic Factors for Stroke, Coronary Event, Death
Yaggi; J Clin Sleep Med 2009
Prognostic Factor Hazard Ratio 95% C.I Score
Age
<60
60-70
>70
1.00
2.60
5.03
--
1.78-3.80
3.45-7.33
1
2
4
Previous CVD 1.75 1.25-2.45 2
Hypertension or DM 1.52 1.02-2.18 2
Smoking 1.54 1.06-2.20 2
Obstructive Sleep Apnea 1.64 1.04-2.42 2
![Page 21: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/21.jpg)
Prognostic Groups for Stroke, Coronary Event, or Death
Risk Group
Outcome
n/N (%)
Low Risk (1-5) 44/881 5.0
Intermediate Risk (6-7) 90/590 15.3
High Risk (8-12) 57/168 33.9
Yaggi; J Clin Sleep Med 2009
![Page 22: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/22.jpg)
Prognostic Groups for Stroke, Coronary Event, or Death (cont.)
Yaggi; J Clin Sleep Med 2009
(VA) Validation Cohort(Yale) Development CohortKaplan-Meier Estimates for Event-Free Survival
(TIA, Stroke, M.I.,Death)
0 20 40 60 800 20 40 60 80
1.0
0.8
0.6
0.4
0.2
0.0 Pro
babi
lity
of
Eve
nt-F
ree
Sur
viva
l
1 2 3 4 5 6
Years
1 2 3 4 5 6
Years
![Page 23: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/23.jpg)
Epidemiologic Studies Linking OSA to Cardiovascular Outcomes
• Cardiovascular Disease: Shahar, AJRCCM, 2001
• Stroke: Arzt, AJRCCM, 2005• Stroke: Munoz, Stroke, 2006• Stroke Mortality: Sahlin, Arch Int Med, 2008• Myocardial Infraction: Peker, Eur Respir J, 2006• Fatal/Non-fatal Cardiovascular Events: Marin, Lancet, 2005• Sudden Death: Gami, NEJM, 2005• All Cause Mortality: Young/Marshall, Sleep, 2008
![Page 24: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/24.jpg)
Outline
• Epidemiologic evidence linking sleep-disordered Epidemiologic evidence linking sleep-disordered breathing to cardiovascular outcomesbreathing to cardiovascular outcomes
• Mechanisms of Stroke in sleep-disordered breathing
![Page 25: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/25.jpg)
Mechanisms of Stroke in Sleep-Disordered Breathing
1. Intermittent hypoxia
2. Sympathetic activation
3. Mechanical load
4. Snoring and carotid atherosclerosis
5. Impaired sleep and metabolic dysregulation
![Page 26: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/26.jpg)
1. Intermittent Hypoxia
• Repetitive episodes of hypoxia and reoxygenation
• Activation of vascular inflammatory pathways leading to atherosclerosis
• Severity of sleep apnea correlates with carotid intimal medial thickness
Ryan; Circulation 2005Saletu; J Neurobiol 2007Savransky; AJRCCM 2007Szaboova; Resp Physiol and Neurobiol 2007
![Page 27: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/27.jpg)
Lavie; Sleep Med Review 2004
![Page 28: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/28.jpg)
2. Sympathetic Activation
Wolk; Circulation 2003
![Page 29: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/29.jpg)
Circadian Blood Pressure and “Nondipping”
Apnea No Apnea
Somers; J Clin Invest 1995 Ancoli-Israel; Chest 2002Hla; Sleep 2008
![Page 30: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/30.jpg)
Normal Circadian Variation in Vascular Events
Marler; Stroke 1989
![Page 31: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/31.jpg)
Day-Night Pattern of Sudden Death from Cardiac Causes in 78 Persons with and 34 Persons without Obstructive Sleep Apnea (OSA) and in the General Population
Gami, A. et al. N Engl J Med 2005;352:1206-1214
Day-night Pattern of Sudden Death in Obstructive Sleep Apnea
Gami; NEJM 2005
![Page 32: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/32.jpg)
Association of Nocturnal Arrhythmias with Sleep-disordered Breathing
Mehra; AJRCCM 2006
Arrhythmia Type Odds ratio (95% CI)
Nonsustained ventricular tachycardia 3.40 (1.03-11.2)
Complex ventricular ectopy 1.74 (1.11-2.74)
Atrial fibrillation 4.02 (1.03-15.74)
![Page 33: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/33.jpg)
3. Mechanical Load in Sleep Apnea
Bradley and Floras (eds); Marcel Decker 2000
END OF APNEABASELINE
Obstructive Apnea
• ↑ Transmural pressure (afterload)• ↓ Cardiac output
(Mueller maneuver)
![Page 34: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/34.jpg)
Obstructive Apneas and Cerebral Blood flow
Balfors ; AJRCCM 1994
![Page 35: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/35.jpg)
4. Snoring and Carotid Artery Atherosclerosis
• Vibratory stimuli causes pathologic damage to arterial wall endothelial cells1,2
• Snores originate in the upper airway during sleep and result in vibrations of the pharyngeal wall and associated structures
• The proximity of the carotid bifurcation to the lateral pharyngeal wall exposes it to these vibrations and may cause pathologic damage to the arterial wall endothelium3
1. Curry; Muscle and Nerve 20022. Puig; Sleep 20053. Hedner; Sleep and Beathing 1994
![Page 36: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/36.jpg)
4. Snoring and Carotid Artery Atherosclerosis
• Cross-sectional study of 110 subjects who underwent PSG with quantification of snoring, carotid artery ultrasound
• Simultaneous quantification of femoral artery atherosclerosis as a distant (from the upper airway) control artery
• There was a significant increase in carotid artery atherosclerosis (in a dose-response fashion) with increased snoring, but not femoral atherosclerosis
Lee; Sleep 2008
![Page 37: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/37.jpg)
Covariate Odds Ratio C.I.
Age, per decade 3.2 1.4-7.2
Male Sex 4.6 1.4-15.2
Smoking History 3.9 1.1-15.2
Hypertesnion 4.7 1.3-15.7
Snoring, % sleep time
0-25 -
25-50 1.7 0.4-6.9
>50 10.5 2.1-51.8
Lee; Sleep 2008
4. Snoring and Carotid Artery Atherosclerosis
![Page 38: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/38.jpg)
5. Impaired Sleep and Metabolic Dysregulation
• ↓ Glucose tolerance and ↓ insulin release1
• ↑hunger and appetite and associated changes in leptin and ghrelin2
• Short sleep duration ↑ risk type 2 diabetes3
• Sleep apnea associated with insulin resistance and glucose intolerance4,5 1. Spiegel; Lancet 1999
2. Spiegel; Ann Intern Med 20043. Yaggi; Diabetes Care 20064. Punjabi; AJRCCM 20015. IP; AJRCCM 2001
![Page 39: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/39.jpg)
Obstructive Sleep Apnea as a Risk Factor for Type 2 Diabetes Mellitus Covariate Unadjusted HR (95%CI) Adjusted HR (95% CI)
Age 0.99 (0.98-1.02) 1.00 (0.98-1.02)
Gender 1.41 (0.44-4.51) 1.09 (0.34-3.57)
Race (non-caucasian) 1.35 (0.64-2.85) 1.13 (0.56-2.30)
Fasting Glucose 1.04 (1.04-1.05) 1.05 (1.03-1.06)
BMI 1.06 (1.03-1.09) 1.04 (1.01-1.07)
Change in BMI 0.73 (0.69-0.78) 0.76 (0.70-0.83)
Sleep Apnea* 1.53 (1.21-94) 1.43(1.10-1.86)
Botros; Am J Med 2009
* Per Quartile of AHI
![Page 40: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/40.jpg)
Sleep Apnea and Diabetes: The Impact of CPAP Treatment
Botros; Am J Med 2009
![Page 41: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/41.jpg)
Sleep Apnea Syndrome(Syndrome “Zzzz”)
Metabolic Syndrome(Syndrome X)
•Central Obesity•Hypertension •Insulin Resistance
•High Triglycerides•Low HDL
•Cyclic Hypoxia•Nocturnal Sympathetic Activation•Sleep Loss
![Page 42: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/42.jpg)
Cyclic HypoxiaOxidative stressInflammationEndothelial dsfxn. Atherosclerosis
Nocturnal Sympathetic ActivationBlood pressure surgesCardiac arrhythmia∆s Cerebral blood flow
MechanicalLoadVibration injury↑ afterload↓ cardiac output
Metabolic DysregulationGlucose IntoleranceInsulin ResistanceObesityDiabetes
Cardiovascular disease and Stroke
![Page 43: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/43.jpg)
Outline
• Epidemiologic evidence linking sleep-disordered Epidemiologic evidence linking sleep-disordered breathing to cardiovascular outcomesbreathing to cardiovascular outcomes
• Mechanisms of stroke in sleep-disordered breathingMechanisms of stroke in sleep-disordered breathing
• Impact of CPAP treatment on cerebrovascular risk
![Page 44: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/44.jpg)
Cardiovascular outcomes in Obstructive Sleep Apnea With and Without Treatment
Marin; Lancet 2005
![Page 45: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/45.jpg)
Stroke Mortality in Sleep Apnea With and Without Treatment
Martinez-Garcia; AJRCCM 2009
![Page 46: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/46.jpg)
Impact of CPAP on Blood Pressure
Haentjens; Arch Int Med 2007
Severity of Sleep Apnea Effective CPAP Use
![Page 47: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/47.jpg)
Inferring Coronary Heart Disease and Stroke Risk Reduction from Antihypertensive effect of
CPAP
Collins; Lancet 1990
![Page 48: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/48.jpg)
CPAP Treatment and Cerebrovascular Risk
• ↓ Blood pressure1
• ↓ Sympathetic activity and catecholamines2,5
• ↓ Recurrent atrial fibrillation3
• ↑ Left ventricular function4
• ↓ Early Signs of Atherosclerosis5
1. Haentjens,;Arch Int Med 20072. Faccenda; AJRCCM 20013. Kanagol; Circulation 20034. Kaneko;NEJM 20035. Drager; AJRCCM 2007
![Page 49: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/49.jpg)
Study Design: CPAP Treatment Decreases Early Signs of Atherosclerosis
Randomized(without comorbidity)
N=24
No treatmentN=12
CPAP treatmentN=12
Vascular Parameters
Intima-media thicknessArterial stiffnessCarotid diameter24 hour BPLipid profileCatecholaminesC-reactive protein
4 months of follow-up
Assessed for Eligibility
(severe OSA)N=400
Exclusion N=376HypertensionDiabetes Heart FailureCoronary Artery DiseaseStrokeSmoking
Drager; AJRCCM 2007
![Page 50: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/50.jpg)
Primary Outcome:Intima-Media Thickness
Drager; AJRCCM 2007
![Page 51: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/51.jpg)
Secondary Outcome: Carotid-Femoral Pulse-Wave Velocity
Drager; AJRCCM 2007
![Page 52: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/52.jpg)
Serum and Blood Pressure Measures in Control and CPAP groups
Control Group CPAP group
Measures Baseline 4 mo Baseline 4 mo p valueBMI 29.7 29.4 29.9 29.8 NS
Systolic BP 122 121 123 119 NS
Diastolic BP 66 67 73 69 NS
Total Cholesterol 226 224 242 235 NS
LDL 147 145 158 152 NS
HDL 48 47 51 49 NS
C-reactive Protein 3.1 3.3 3.7 2.0 <0.001
Catecholamines 362 357 365 205 <0.001
Drager; AJRCCM 2007
![Page 53: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/53.jpg)
Rationale:Treatment of Sleep Apnea in TIA• Patients with acute TIA are ideal candidates for
prevention of recurrent vascular events– 300,000 TIAs occur annually in U.S.1
– No neurologic deficit (< 24 hours)– High risk of poor outcomes despite prevention strategies:
• 25% will have stroke, cardiovascular event, or death 90 days post-TIA (half of events occur within first 72 hrs)2
• New approach to reduce recurrent vascular event rate is needed (particularly in acute post-TIA period)
1. Johnston, NEJM, 20022. Johnston, JAMA, 2000
![Page 54: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/54.jpg)
Methods: OverviewDesign: Randomized controlled trial, (90days)
Sample: TIA patients (focal neurologic deficit < 24 hoursconfirmed by study neurologist)
Setting: Emergency departments/inpatients at 3 CT hospitals
Exclusions: Established OSA, mechanical ventilation, COPDrequiring O2, pregnancy, symptom onset >72hrs, lifeExpectancy <6 months, residence outside CT
Intervention: Early/immediate Auto-CPAP (ideally within 1st
or 2nd night of TIA) for 90 days (stopped if no evidenceof sleep apnea/response to flow limitation)
Control: Usual care
![Page 55: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/55.jpg)
Outcomes
• Primary outcomes– Sleep apnea prevalence (baseline portable study)
– CPAP adherence rates• No use
• Some use (< 4hr/night or < 70% of nights)
• Good use (≥ 4hr/night and ≥ 70% of nights)
• Secondary Outcome (preliminary data)– 90-day post-TIA recurrent vascular event rate
• TIA, stroke, myocardial infarction, hospitalization for CHF, or death
• Intention-to-treat, CPAP use category (pre-specified)
![Page 56: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/56.jpg)
Prevalence of Obstructive Sleep Apnea
Characteristic Baseline Sleep Study 90-day Sleep Study
OSA prevalence n/N (%) 12/21 (57) 27/45 (59)
AHI: Mean (+/-SD) 11.1 (12) 11.0 (13)
AHI: median, range 6.5, 0-63 6.7, 0-62
Yaggi; Stroke 2010 (In Press)
![Page 57: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/57.jpg)
Time to CPAP or Portable Sleep Study
Time
Intervention
CPAP
(n=45)
Control
Sleep study
(N=25)
From TIA symptom onset, Hours: mean (+/-SD) 39.4 (23) 45.0 (37)
<24 hours: n (%) 8 (18) 4 (16)
≥ 24 < 48 hours: n (%) 27 (60) 15 (60)
≥ 48 hours 10 (22) 6 (24)
Yaggi; Stroke 2010 (In Press)
![Page 58: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/58.jpg)
Auto-Titrating CPAP Use
CPAP Use Category
Intervention Patients on CPAP
N=29
Number hrs/night used: mean (+/-SD)
Range
5.6 (1.9)
1.5-8.5
CPAP Use: N (%) -
None: 0 hrs/night or 0 nights 0 (0)
Some: <4 hrs/night or <70% nights 14 (48)
Good: ≥4 hrs/night and ≥ 70% nights 15 (52)
Yaggi; Stroke 2010 (In Press)
![Page 59: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/59.jpg)
Recurrent Vascular Events:Overall
(Intention-To-Treat)
(+) Outcome (-) Outcome
Intervention 1
(2%)
44 45
Control 3
(12%)
22 25
P=0.13; 2-sided
Yaggi; Stroke 2010 (In Press)
![Page 60: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/60.jpg)
Recurrent Vascular Events: Evidence of Sleep Apnea
(CPAP Use Category)(+) Outcome (-) Outcome
Good 0
(0%)
15 15
Some 1
(7%)
13 14
None 3
(16%)
16 19
P=0.09; 2-sidedYaggi; Stroke 2010 (In Press)
![Page 61: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/61.jpg)
Summary• Sleep apnea is a valid syndrome of stroke risk.
• Epidemiologic studies demonstrate that sleep apnea is independently associated with hypertension, stroke, myocardial infarction, fatal and non-nonfatal cardiovascular events, and sudden death, all cause mortality
• Physiological studies suggest mechanisms (intermittent hypoxia, sympathetic activation, changes in cerebral blood flow, mechanical load, metabolic dyregulation) whereby sleep apnea provides a substrate for the development of stroke.
![Page 62: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/62.jpg)
Implications
• The high prevalence of sleep apnea confers a high population attributable risk for cerebrovascular outcomes
• CPAP treatment is likely result in decreased cerebrovascular risk.
• Longer-term randomized controlled trials examining the impact of treatment on cerebrovascular outcome events are needed.
![Page 63: Sleep-Disordered Breathing and Stroke Klar Yaggi, M.D., M.P.H. Assistant Professor Yale University School of Medicine Clinical Epidemiology Research Center.](https://reader035.fdocuments.net/reader035/viewer/2022062717/56649e225503460f94b0e63a/html5/thumbnails/63.jpg)
Acknowledgements
John Concato, M.D.
Vahid Mohsenin, M.D.
Judy Lichtman, Ph.D.
Rachel Lampert, M.D.
Dawn Bravata, M.D. (Indianapolis)
Kingman Strohl, M.D. (Cleveland)
Mark Gorman, M.D. (Vermont)
Zhu Wang, Ph.D.
Nader Botros, M.D., M.P.H.
Neomi Shah, M.D., M.P.H.
Bernardo Selim, M.D.
Frederick Struve, Ph.D
Vincent McClain, M.D.
Yale Center for Sleep Medicine VA CT Center for Sleep MedicineVA Clinical Epidemiology Research CenterVA HSR&D Research CDA/Merit ProgramVA CSR&D Merit Program